Patent Term Extended Under 35 U.S.C. 156(e)(2) A second interim extension of the term of U.S. Patent No. Re. 30,633 has been granted under 35 U.S.C. 156(e)(2) for a period of one year from the first extended expiration date of the patent. On May 16, 1994, a first interim extension was granted under 35 U.S.C. 156(e)(2) extending the term of the patent for a period of one year. See 1163 OG 12. The first extended term of the patent expires on April 19, 1995. An application for patent term extension was filed by the patent owner of record The Board of Trustees of the University of Illinois based on approval of the product "DEMADEX" by the Food and Drug Administration. The initial PTO review of the application to date indicates that the `633 patent would be eligible for a maximum five-year extension of the patent term under 35 U.S.C. 156(g)(6)(B).